Differential systemic arterial and venous actions and consequent cardiac effects of vasodilator drugs
- 30 April 1982
- journal article
- review article
- Published by Elsevier in Progress in Cardiovascular Diseases
- Vol. 24 (5) , 353-374
- https://doi.org/10.1016/0033-0620(82)90019-6
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Sustained Effectiveness of Converting-Enzyme Inhibition in Patients with Severe Congestive Heart FailureNew England Journal of Medicine, 1980
- Presynaptic receptor systems on cardiac sympathetic nervesLife Sciences, 1979
- Sustained Reduction of Cardiac Impedance and Preload in Congestive Heart Failure with the Antihypertensive Vasodilator PrazosinNew England Journal of Medicine, 1977
- Accentuated Vascular and Endocrine Response to Sq 20881 in HypertensionNew England Journal of Medicine, 1977
- Vasodilator Therapy of Cardiac FailureNew England Journal of Medicine, 1977
- Combined dopamine and nitroprusside therapy in congestive heart failure. Greater augmentation of cardiac performance by addition of inotropic stimulation to afterload reduction.Circulation, 1977
- Oral hydralazine therapy for chronic refractory heart failure.Circulation, 1976
- Combined Therapy with Vasodilator Drugs and Beta-Adrenergic Blockade in HypertensionCirculation, 1972
- The Effects of Nitroglycerin and Amyl Nitrite on Arteriolar and Venous Tone in the Human ForearmCirculation, 1965
- The Circulatory Effects of Intravenous Phentolamine in ManCirculation, 1965